195 related articles for article (PubMed ID: 34512711)
1. A Prognostic Signature Constructed by
Han S; Zhu W; Yang W; Guan Q; Chen C; He Q; Zhong Z; Zhao R; Xiong H; Han H; Li Y; Sun Z; Hu X; Tian J
Front Genet; 2021; 12():646818. PubMed ID: 34512711
[TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
4. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
5. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
7. Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma.
Wang T; Wen W; Liu H; Zhang J; Zhang X; Wang Y
Front Med (Lausanne); 2021; 8():793401. PubMed ID: 35004767
[No Abstract] [Full Text] [Related]
8. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
9. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
[TBL] [Abstract][Full Text] [Related]
10. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
Li X; Lei Y
Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
12. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
[TBL] [Abstract][Full Text] [Related]
13. A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
Guan E; Tian F; Liu Z
Oncol Lett; 2020 Feb; 19(2):1351-1367. PubMed ID: 31966067
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
16. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
[TBL] [Abstract][Full Text] [Related]
17. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
Liu Y; Zhang L; Lei X; Yin X; Liu S
Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.
Yang B; Zhang M; Luo T
Front Genet; 2020; 11():517362. PubMed ID: 33193601
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]